Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
- 8 January 2007
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 136 (4), 539-548
- https://doi.org/10.1111/j.1365-2141.2006.06458.x
Abstract
International audienceCD4(+)/CD56(+) haematodermic neoplasm or 'early' plasmacytoid dendritic cell leukaemia/lymphoma (pDCL) was described as a disease entity in the last World Health Organisation/European Organisation for Research and Treatment of Cancer classification for cutaneous lymphomas. These leukaemia/lymphomas co-express CD4 and CD56 without any other lineage-specific markers and have been identified as arising from plasmacytoid dendritic cells. Despite a fairly homogeneous pattern of markers expressed by most pDCL, numerous distinctive features (e.g. cytological aspects and aberrant marker expression) have been reported. This may be related to the 'lineage-independent developmental' programme of dendritic cells, which may be able to develop from either immature or already committed haematopoietic progenitors. This highlights the need for specific validated markers to diagnose such aggressive leukaemia. Here, we propose--among others (e.g. T-cell leukaemia 1)--blood dendritic cell antigen-2 and high levels of CD123 expression as potential markers. In addition, we propose a multidisciplinary approach including several fields of haematology to improve pDCL diagnosisKeywords
This publication has 77 references indexed in Scilit:
- Ikaros is required for plasmacytoid dendritic cell differentiationPublished by American Society of Hematology ,2006
- The role of gemtuzumab ozogamicin in acute leukaemia therapyBritish Journal of Haematology, 2006
- The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giantsBritish Journal of Dermatology, 2005
- CD4+ CD56+ Blastic Tumor Cells Express CD101 MoleculesJournal of Investigative Dermatology, 2005
- Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cellsImmunobiology, 2004
- Frontline: Neuropilin‐1: a surface marker of regulatory T cellsEuropean Journal of Immunology, 2004
- Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?British Journal of Dermatology, 2003
- Redefinition of lymphoid progenitorsNature Reviews Immunology, 2002
- CD56+/CD4+ Lymphomas and Leukemias Are Morphologically, Immunophenotypically, Cytogenetically, and Clinically DiverseAmerican Journal of Clinical Pathology, 2001
- Chronic Myelomonocytic Leukemia Derived from a Possible Common Progenitor of Monocytes and Natural Killer CellsLeukemia & Lymphoma, 2000